CEBPZ and acute myeloid leukemia: Consequently, we performed a retrospective study on patients with KIT mutant (KIT mut)/CBF-neg AML and investigated the clinical characteristics, treatment procedures and survival to provide preliminary clues into the individual treatment strategy of the subgroup.